NCT Number: NCT02526368
Phase: EARLY PHASE1
Trial Summary: This pilot clinical trial studies how well magnetic resonance spectroscopic imaging (MRSI) with hyperpolarized carbon C13 pyruvate works in finding prostate cancer that exhibits po – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of California, San Francisco
Acronym: pyruvate
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives